Vaccine Technologies Inc. Report issue

For profit Phase 2
Founded: Boston MA United States (2003)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2008
NCT00624975
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now